Plaque Image Characteristics, Hyperhomocysteinemia, and Gene Polymorphism of Homocysteine Metabolism-Related Enzyme (MTHFR C677T) in Acute Coronary Syndrome

Cell Biochemistry and Biophysics - Tập 66 Số 2 - Trang 403-407 - 2013
Haiyan Xu1, Chang-Mei Liu2, Qinghai Wang3
1Affiliated Hospital of Binzhou Medical College
2Department of Endocrinology, Affiliated Hospital of Binzhou Medical College, Binzhou, People’s Republic of China
3Department of Cardiology, Central Hospital of Shengliyoutian, Dongying, People’s Republic of China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Rossi, M. L., Marziliano, N., Merlini, P. A., et al. (2004). Different quantitative apoptotic traits in coronary atherosclerosis plaques from patients with stable angina pectoris and acute coronary syndromes. Circulation, 110, 1767–1773.

Nakai, K., Itoh, C., Nakai, K., et al. (2001). Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD. American Journal of Cardiovascular Drugs, 1, 353–361.

Ortolani, P., Marzocchi, A., Marrozzini, C., et al. (2004). Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. Italian Heart Journal, 5, 189–196.

Dinckalm, H., Aksoy, N., Aksoy, M., et al. (2003). Effect of homocysteine lowering therapy on vascular endothelial function and exercise performance in coronary patients with hyperhomocysteinaemia. Acta Cardiologica, 58, 389.

Frosst, P., Blam, H. J., Milos, R., et al. (1995). A candidate genetic risk factor for vascular disease: a common mutation methylenetetrahydrofolate. Nature Genetics, 10, 111–113.

Nakai, K., Fusazaki, T., Suzuki, T., et al. (2000). Genetic polymorphism of 5,10-methylenetetrahydrofolate increases risk of myocardial infarction and is correlated to elevated levels of homocysteine in the Japanese general population. Coronary Artery Disease, 11, 47–51.

Nakai, K., Itoh, C., Nakai, K., et al. (2001). Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD[J]. American Journal of Cardiovascular Drugs, 1(5), 353–361.